Gleason Group, Inc. Merck & Co., Inc. Transaction History
Gleason Group, Inc.
- $962 Million
- Q3 2025
A detailed history of Gleason Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gleason Group, Inc. holds 659 shares of MRK stock, worth $61,194. This represents 0.01% of its overall portfolio holdings.
Number of Shares
659
Previous 636
3.62%
Holding current value
$61,194
Previous $50,000
10.0%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding MRK
# of Institutions
3,878Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...